HNF4A and prostate carcinoma: Real-time qRT-PCR and immunoblot analyses of HNF4α expression performed in a panel of immortalized nonmalignant prostatic epithelial and prostate cancer cell lines revealed that HNF4α exhibited a significant decreased expression in all tested prostate cancer cell lines as compared with immortalized prostatic epithelial cell lines (Supplementary Fig. S1a).